BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2168061)

  • 1. Detection of cardiac allograft rejection using radionuclide techniques.
    Addonizio LJ
    Prog Cardiovasc Dis; 1990; 33(2):73-83. PubMed ID: 2168061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of myocardial imaging agents by rejected hearts.
    Bergsland J; Carr EA; Carroll M; Wright JW; Feldman MJ; Massucci J; Bhayana JN; Gona JM
    J Heart Transplant; 1985; 4(5):536-40. PubMed ID: 3039099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is In-111 antimyosin antibody a useful diagnostic marker for evaluation of early cardiac allograft rejection?
    Ueda K; Takeda K; LaFrance ND; Solez K; Baumgartner WA; Reitz BA; Herskowitz A
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):778-81. PubMed ID: 2831646
    [No Abstract]   [Full Text] [Related]  

  • 4. Uptake of myocardial imaging agents by rejecting and nonrejecting cardiac transplants. A comparative clinical study of thallium-201, technetium-99m, and gallium-67.
    Yamamoto S; Bergsland J; Michalek SM; Carroll M; Gona JM; Balu D; Carr EA
    J Nucl Med; 1989 Sep; 30(9):1464-9. PubMed ID: 2671299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide imaging in myocardial sarcoidosis. Demonstration of myocardial uptake of technetium pyrophosphate99m and gallium.
    Forman MB; Sandler MP; Sacks GA; Kronenberg MW; Powers TA
    Chest; 1983 Mar; 83(3):578-80. PubMed ID: 6297857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction.
    Takeda K; LaFrance ND; Weisman HF; Wagner HN; Becker LC
    J Am Coll Cardiol; 1991 Feb; 17(2):519-26. PubMed ID: 1846888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indium-111 myosin-specific antibodies and technetium-99m pyrophosphate in the detection of acute cardiac rejection of transplanted hearts: studies in a heterotopic rat heart model.
    Takeda K; Ueda K; Scheffel U; Ravert H; LaFrance ND; Baumgartner WA; Reitz BA; Herskowitz A; Wagner HN
    Eur J Nucl Med; 1991; 18(7):461-6. PubMed ID: 1833199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging necrotic myocardium: detection with 99mTc-pyrophosphate and radiolabeled antimyosin.
    Khaw BA; Haber E
    Cardiol Clin; 1989 Aug; 7(3):577-88. PubMed ID: 2548722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal Fab antimyosin in cardiac imaging.
    Johnson LL
    Clin Cardiol; 1992 Mar; 15(3):145-53. PubMed ID: 1551261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide assessment of myocardial injury in a heterotopic rat heart transplant model.
    McGregor CG; Hannan WJ; Wheatley DJ; Smith AF; Muir AL
    Int J Nucl Med Biol; 1984; 11(2):189-94. PubMed ID: 6090331
    [No Abstract]   [Full Text] [Related]  

  • 11. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab.
    Addonizio LJ; Michler RE; Marboe C; Esser PE; Johnson LL; Seldin DW; Gersony WM; Alderson PO; Rose EA; Cannon PJ
    J Am Coll Cardiol; 1987 Mar; 9(3):555-64. PubMed ID: 3546461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m pyrophosphate in diagnosis of acute cardiac rejection in the rat with effect of cyclosporine: concise communication.
    McGregor CG; Hatz R; Aziz S; Billingham MB; McDougall IR
    J Nucl Med; 1984 Aug; 25(8):870-3. PubMed ID: 6086860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate.
    Khaw BA; Strauss HW; Moore R; Fallon JT; Yasuda T; Gold HK; Haber E
    J Nucl Med; 1987 Jan; 28(1):76-82. PubMed ID: 3025386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m pyrophosphate and indium-111 antimyosin antibody scintigraphy appear to be comparable methods for infarct detection.
    Willerson JT; Buja LM
    J Am Coll Cardiol; 1991 Feb; 17(2):527-9. PubMed ID: 1846889
    [No Abstract]   [Full Text] [Related]  

  • 15. Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts.
    Isobe M; Haber E; Khaw BA
    Circulation; 1991 Sep; 84(3):1246-55. PubMed ID: 1884451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimyosin imaging in cardiac transplant rejection.
    Johnson LL; Cannon PJ
    Circulation; 1991 Sep; 84(3 Suppl):I273-9. PubMed ID: 1884496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of cardiac transplantation rejection in primates using two new antimyosin agents.
    Vaccarino RA; Sanchez JE; Johnson LL; Wang TS; Seldin DW; Marboe C; Egbe P; Bhatia K; Rose EA; Khaw BA
    J Nucl Med; 1992 Nov; 33(11):1994-9. PubMed ID: 1432161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to diagnose cardiac treatment rejection with Tc99m-PYP images.
    McKillop JH; McDougall IR; Goris ML; Mason JW; Reitz BA
    Clin Nucl Med; 1981 Aug; 6(8):375-7. PubMed ID: 6266731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive detection of rejection of transplanted hearts with indium-111-labeled lymphocytes.
    Eisen HJ; Eisenberg SB; Saffitz JE; Bolman RM; Sobel BE; Bergmann SR
    Circulation; 1987 Apr; 75(4):868-76. PubMed ID: 3030580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium 99m sestamibi.
    Rodney RA; Johnson LL; Blood DK; Barr ML
    J Heart Lung Transplant; 1994; 13(2):173-80. PubMed ID: 8031797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.